Discontinuation of treatment with Natalizumab after 24 courses. Report from spontaneous, observational, prospective study (TYSTOP)

Autor: Clerico, M, De Mercanti, S, Piazza, F, Versino, E, Gned, D, Gibbin, M, Brescia Morra, V, Lanzillo, R, Amato, L, Quarantelli, M, Ghezzi, A, Bianchi, A, Baroncini, D, Ferrò, MT, Vitetta, F, D’Onghia, M, Paolicelli, D, Trojano, M, Durelli L., SALEMI, Giuseppe, REALMUTO, Sabrina

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3658::046b213eff69323b760d1ba125cce587
http://hdl.handle.net/10447/100464

Natalizumab discontinuation after the 24th course: which is the way? The TY-STOP study

Autor: Clerico, Marinella, DE MERCANTI, STEFANIA FEDERICA, Piazza, F, Gned, D, Brescia Morra, V, Lanzillo, R, Amato, L, Quarantelli, M, Ghezzi, A, Bianchi, A, Baroncini, D, Gibbin, M, Vargas, J, Salemi, G, Realmuto, S, Ferro, Mt, Vitetta, F, Sola, P, Paolicelli, D, Trojano, M, Durelli, Luca

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______970::9f60fce9d52b2082cffdf802181642b0
http://hdl.handle.net/2318/153071

Looking for the best therapeutical strategy after the 24th natalizumab administration. The TY-STOP study

Autor: Marinella CLERICO, Mercanti, S., Piazza, F., Gned, D., Morra, V. Brescia, Lanzillo, R., Amato, L., Quarantelli, M., Ghezzi, A., Bianchi, A., Baroncini, D., Gibbin, M., Vargas, J., Salemi, G., Realmuto, S., Ferro, M. T., Vitetta, F., Mascolo, L., Paolicelli, D., Trojano, M., Durelli, L.

Publikováno v: Multiple sclerosis 18 (2012): 450–450.
info:cnr-pdr/source/autori:Clerico, M.; De Mercanti, S.; Piazza, F.; Gned, D.; Morra, V. Brescia; Lanzillo, R.; Amato, L.; Quarantelli, M.; Ghezzi, A.; Bianchi, A.; Baroncini, D.; Gibbin, M.; Vargas, J.; Salemi, G.; Realmuto, S.; Ferro, M. T.; Vitetta, F.; Mascolo, L.; Paolicelli, D.; Trojano, M.; Durelli, L./titolo:Looking for the best therapeutical strategy after the 24th natalizumab administration. The TY-STOP study/doi:/rivista:Multiple sclerosis/anno:2012/pagina_da:450/pagina_a:450/intervallo_pagine:450–450/volume:18
Web of Science

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::0f746e6eb87bda3c45567e2a8f072290
http://www.cnr.it/prodotto/i/444119

Alemtuzumab treatment in MS how do the Treg cell function and suppressor cytokine mRNA (IL-10, TGF-beta, IL_27) levels change? 24-month immunological report during 323 and 324 genzyme trials

Autor: DE MERCANTI, STEFANIA FEDERICA, Cucci, Marie Angele, Viglietti, E, Giai Via, A, Taverna, Daniela, Cimino, D, Rolla, Simona, Bardina, Valentina, Novelli, Francesco, Vargas, J, Gibbin, M, Piazza, F, Vladic, A, B. r. i. n. a. V., Habek, M, Cocco, E, Annavazzi, P, Horakova, D, Clerico, Marinella, Durelli, Luca

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______970::31b4f179a51380dfc82718a4718a010a
http://hdl.handle.net/2318/1562256

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.